
Pre-eclampsia: Prediction and Prevention
Pre-eclampsia is new high blood pressure (140/90 mmHg or more) after 20 weeks with protein in the urine or organ damage; it affects about 2–8% of pregnancies and is a leading cause of maternal and fetal illness and death
Prediction starts with the clinical history: high-risk and moderate-risk factors identify women who need prevention without any special test
Combined first-trimester screening (history, mean arterial pressure, uterine artery Doppler, and placental growth factor) can detect most preterm pre-eclampsia where available
Low-dose aspirin from 12 weeks (before 16) cuts the risk of preterm pre-eclampsia in high-risk women; calcium helps where dietary intake is low
Blood tests such as the sFlt-1 to placental growth factor ratio help to rule out or confirm disease in women with symptoms, not to screen well women
| Topic | Details |
|---|---|
| Rule | One high-risk factor, or two or more moderate-risk factors means offer low-dose aspirin (NICE, ACOG, and FIGO use a similar approach) |
| High-risk factors | Previous pre-eclampsia or hypertension in pregnancy, chronic hypertension, diabetes before pregnancy, chronic kidney disease, autoimmune disease (lupus, antiphospholipid syndrome), and multiple pregnancy |
| Moderate-risk factors | First pregnancy, age 40 or over, body mass index above 30–35, family history of pre-eclampsia, interval above 10 years since the last birth; some guidelines add IVF, low income, and previous small baby, abruption, or stillbirth |
| Why | The history alone catches about a third to half of cases; adding scans and blood tests improves detection |
| Test | What it adds |
|---|---|
| Combined first-trimester screening (11–13+6 weeks) | Maternal history, mean arterial pressure, uterine artery pulsatility index, and placental growth factor, combined in a validated algorithm (Fetal Medicine Foundation model); about 75–90% of preterm pre-eclampsia is found at a 10% false-positive rate (varies between studies) |
| Mean arterial pressure | Measured with a validated device, seated, in both arms; higher values early in pregnancy increase risk |
| Uterine artery Doppler | At 11–14 weeks (as part of combined screening) or 20–24 weeks; a high pulsatility index or notching means high resistance and risk; not useful alone in low-risk women |
| Placental growth factor and sFlt-1 | Low placental growth factor, or a high sFlt-1 to placental growth factor ratio, supports the diagnosis in women with suspected pre-eclampsia (20–35 weeks); a ratio of 38 or less makes pre-eclampsia unlikely within a week (cut-offs depend on the assay) |
| Basic tests in suspected disease | Urine protein (strip, protein-to-creatinine ratio), blood count with platelets, liver and kidney tests, uric acid |
| Practical point | Where advanced tests are not available, risk factors, BP, and urine at every visit remain the mainstay |
| Measure | Details |
|---|---|
| Low-dose aspirin | 75–150 mg once daily at night (FIGO suggests 150 mg; ACOG suggests 81 mg) from 12 weeks, ideally before 16 weeks, until 36 weeks or birth; lowers preterm pre-eclampsia by roughly 60% in high-risk women when started early (from trials; effect varies) |
| Calcium | WHO: 1.5–2 g elemental calcium a day from 20 weeks in populations with low intake; India recommends about 1 g a day; give with iron at different times |
| Control chronic disease | Treat chronic hypertension (labetalol, nifedipine, or methyldopa; stop ACE inhibitors and angiotensin blockers); optimise diabetes and kidney disease |
| Lifestyle | Healthy weight before pregnancy, regular moderate physical activity, and balanced diet |
| Antiphospholipid syndrome | Aspirin plus low molecular weight heparin as advised by a specialist |
| What does not prevent it | Vitamins C and E, fish oil, garlic, bed rest, and salt restriction (not proven); low molecular weight heparin alone is not recommended for prevention |
| Spacing and planning | Interpregnancy intervals of 2 years or more and pre-pregnancy counselling |
| Topic | Details |
|---|---|
| Every antenatal visit | BP with the correct cuff, urine protein, weight, symptoms, and fundal height |
| More visits for high-risk women | Every 2–4 weeks from 28 weeks; home BP monitoring where practical |
| Growth scans | From 28–32 weeks in high-risk women, with umbilical artery Doppler if growth is poor |
| Diagnosis | BP of 140/90 or more on two occasions 4 hours apart (or 160/110 once) with protein, or with organ dysfunction |
| Timing of birth | Pre-eclampsia without severe features: about 37 weeks; with severe features: from 34 weeks, earlier if unstable; senior decision |
| After birth | BP at days 3–6 (eclampsia can occur up to 6 weeks), continue treatment as needed; annual BP, glucose, and lipids because lifetime heart disease risk is higher |
| Next pregnancy | Counsel early, start aspirin at 12 weeks, and plan care |
| Topic | Advice |
|---|---|
| Come at once for | Severe headache, blurred vision or flashing lights, pain below the ribs, vomiting, sudden swelling of the face or hands, breathlessness, fits, or reduced movements |
| Take aspirin and calcium daily | Do not stop without advice; tell the doctor about bleeding or stomach pain |
| Plan delivery at a hospital | With a blood bank and newborn care |
| Family | Explain the signs and who to call; plan transport |
Starting aspirin too late or not at all in a high-risk woman
Using the wrong cuff size or measuring BP after a long wait and missing hypertension
Waiting for protein to diagnose pre-eclampsia when other signs are present
Using placental growth factor tests to screen well women
Stopping BP checks after the first trimester or after birth
Giving calcium and iron together so absorption is poor
Forgetting long-term follow-up after pre-eclampsia

No comments:
Post a Comment